BJ9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Benitec Biopharma Inc

Watchlist Manager

Watchlist

Price: 8.61 EUR -1.26% Market Closed

Market Cap: €4.6m

	Benitec Biopharma Inc F:BJ9	US
S	STINAG Stuttgart Invest AG XMUN:STG	DE
	Vale SA BOVESPA:VALE3	BR
	Parker-Hannifin Corp NYSE:PH	US
	Shift4 Payments Inc NYSE:FOUR	US
N	Nine Dragons Paper (Holdings) Ltd XMUN:N3Y	HK
C	China Lilang Ltd F:5LX	CN
	Charter Communications Inc NASDAQ:CHTR	US
B	Boeing Co XHAM:BCO	US
U	Upstart Holdings Inc F:855	US

Profitability Summary

Benitec Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

469%

Low Operating Margin

Negative 3Y Average Operating Margin

-93.392%

Low Net Margin

Negative 3Y Average Net Margin

-94.147%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-86.792%

Negative ROE

-51%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2.005%

Declining ROIC

-1.638% > -4.575%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.